Publication: 304

Inverse correlation between body mass index and clinical outcomes in men with advanced castration-recurrent prostate cancer.
      Google Scholar   
Citation:
Cancer vol 110 (7) 1478-84
Year:
2007
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
Yes
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
CA 36601  
Corr. Author:
 
Authors:
         
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-9181, CALGB-9182, CALGB-90004, CALGB-90006, CALGB-9583, CALGB-9680, CALGB-9780, CALGB-99813
Phases:
2, 3
Keywords:
African Americans, Aged, Androgen Antagonists, Antineoplastic Agents, Hormonal, Body Mass Index, Clinical Trials as Topic, Disease-Free Survival, European Continental Ancestry Group, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Multivariate Analysis, Neoplasm Recurrence, Local, Obesity, Predictive Value of Tests, Prospective Studies, Prostate-Specific Antigen, Prostatic Neoplasms, Severity of Illness Index, Testosterone, United States